WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › ACAD

Which hedge funds own ACAD? ACADIA PHARMACEUTICALS INC, Q2 2026 13F holders

Healthcare · Open on the interactive board

7 of the hedge funds tracked by WhaleCreep disclosed a position in ACAD (ACADIA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $253.0m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.1% of its book. 3 exited: Avidity Partners, Brevan Howard Capital Management, Woodline Partners.

7tracked managers holding
0opened this quarter
3exited this quarter

Which hedge funds hold ACAD? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Point72 Asset Management LPQ2 2026 0.1%$61.6m2,433,168 -6% reduced
Renaissance Technologies LLCQ2 2026 0.0%$32.4m1,282,596 -26% reduced
Marshall WaceQ2 2026 0.0%$44.7m1,764,838 2216% added
Citadel AdvisorsQ2 2026 0.0%$55.2m2,182,177 250% added
D. E. Shaw & CoQ2 2026 0.0%$43.0m1,697,937 133% added
Millennium ManagementQ2 2026 0.0%$14.9m589,924 -16% reduced
Bridgewater AssociatesQ2 2026 0.0%$1.3m50,265 -65% reduced

Exited since the previous quarter

ManagerPrior weightPrior value
Avidity Partners1.1%$288.6k
Brevan Howard Capital Management0.0%$204.4k
Woodline Partners0.6%$15.1m

How has hedge fund ownership of ACAD changed?

QuarterManagers holdingCombined value
Q2 20267$253.0m
Q1 202610$162.0m
Q4 20254$137.7m
Q3 20255$72.4m
Q2 20253$119.9m
Q1 20255$110.4m
Q4 20244$65.2m
Q3 20243$12.1m
Q2 20244$74.4m
Q1 20246$42.5m
Q4 20234$32.9m
Q3 20233$2.8m
Q2 20235$46.2m
Q1 20236$24.2m
Q4 20225$24.0m
Q3 20225$8.3m

Counts every tracked manager that disclosed ACAD in that quarter's filing, including managers that have since stopped filing.